BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31411006)

  • 1. Use of lentiviral pseudotypes as an alternative to reassortant or Triton X-100-treated wild-type Influenza viruses in the neuraminidase inhibition enzyme-linked lectin assay.
    Biuso F; Palladino L; Manenti A; Stanzani V; Lapini G; Gao J; Couzens L; Eichelberger MC; Montomoli E
    Influenza Other Respir Viruses; 2019 Sep; 13(5):504-516. PubMed ID: 31411006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity.
    Eichelberger MC; Couzens L; Gao Y; Levine M; Katz J; Wagner R; Thompson CI; Höschler K; Laurie K; Bai T; Engelhardt OG; ; Wood J
    Vaccine; 2016 Jan; 34(4):458-465. PubMed ID: 26707221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase Antibodies.
    Prevato M; Cozzi R; Pezzicoli A; Taddei AR; Ferlenghi I; Nandi A; Montomoli E; Settembre EC; Bertholet S; Bonci A; Legay F
    PLoS One; 2015; 10(8):e0135383. PubMed ID: 26267900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composition of hemagglutinin and neuraminidase affects the antigen yield of influenza A(H1N1)pdm09 candidate vaccine viruses.
    Shirakura M; Kawaguchi A; Tashiro M; Nobusawa E
    Jpn J Infect Dis; 2013; 66(1):65-8. PubMed ID: 23429089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.
    Changsom D; Lerdsamran H; Wiriyarat W; Chakritbudsabong W; Siridechadilok B; Prasertsopon J; Noisumdaeng P; Masamae W; Puthavathana P
    PLoS One; 2016; 11(4):e0153183. PubMed ID: 27054879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Kim KH; Jung YJ; Lee Y; Park BR; Oh J; Lee YN; Kim MC; Jeeva S; Kang SM
    Virology; 2020 Nov; 550():51-60. PubMed ID: 32882637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay.
    Prevato M; Ferlenghi I; Bonci A; Uematsu Y; Anselmi G; Giusti F; Bertholet S; Legay F; Telford JL; Settembre EC; Maione D; Cozzi R
    PLoS One; 2015; 10(8):e0135474. PubMed ID: 26280677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera.
    Couzens L; Gao J; Westgeest K; Sandbulte M; Lugovtsev V; Fouchier R; Eichelberger M
    J Virol Methods; 2014 Dec; 210():7-14. PubMed ID: 25233882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.
    Sriwilaijaroen N; Wilairat P; Hiramatsu H; Takahashi T; Suzuki T; Ito M; Ito Y; Tashiro M; Suzuki Y
    Virol J; 2009 Aug; 6():124. PubMed ID: 19678928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.
    Panaampon J; Ngaosuwankul N; Suptawiwat O; Noisumdaeng P; Sangsiriwut K; Siridechadilok B; Lerdsamran H; Auewarakul P; Pooruk P; Puthavathana P
    PLoS One; 2012; 7(5):e36318. PubMed ID: 22563489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study.
    Bernard MC; Waldock J; Commandeur S; Strauß L; Trombetta CM; Marchi S; Zhou F; van de Witte S; van Amsterdam P; Ho S; Hoschler K; Lugovtsev V; Weir JP; Montomoli E; Cox RJ; Engelhardt OG; Friel D; Wagner R; Ollinger T; Germain S; Sediri-Schön H
    Front Immunol; 2022; 13():909297. PubMed ID: 35784305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine].
    Smolonogina TA; Desheva IuA; Shaldzhian AA; Grudinin MP; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):72-6. PubMed ID: 22308734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
    Desheva Y; Sychev I; Smolonogina T; Rekstin A; Ilyushina N; Lugovtsev V; Samsonova A; Go A; Lerner A
    PLoS One; 2018; 13(5):e0196771. PubMed ID: 29742168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudotyped Viruses for Influenza.
    Del Rosario JMM; da Costa KAS; Temperton NJ
    Adv Exp Med Biol; 2023; 1407():153-173. PubMed ID: 36920696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
    Skarlupka AL; Bebin-Blackwell AG; Sumner SF; Ross TM
    J Virol; 2021 Aug; 95(17):e0075921. PubMed ID: 34160258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
    Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and Titration of Influenza A Virus Neuraminidase Inhibiting (NAI) Antibodies Using an Enzyme-Linked Lectin Assay (ELLA).
    Kaplan BS; Vincent AL
    Methods Mol Biol; 2020; 2123():335-344. PubMed ID: 32170699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.